Combined meta-analysis of preclinical cell therapy studies shows overlapping effect modifiers for multiple diseases.

Preclinical cell therapy studies are affected by multiple variables, including species, immunosuppression, dose and treatment timing. These data are important when designing preclinical studies before commencing clinical trials.